Nomura Asset Management International’s Phio Pharmaceuticals PHIO Stock Holding History

Nomura Asset Management International’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51K	Buy	+50,000	New	+$57K	﹤0.01%	1329

Other funds holding PHIO

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Nomura Asset Management International's PHIO Position: Q2 2026 in Review

Nomura Asset Management International opened a new position in Phio Pharmaceuticals (PHIO) in Q2 2026: 50,000 shares worth $51K. The stake represents ﹤0.01% of the portfolio and ranks #1329 among its holdings.

24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

Nomura Asset Management International held 50,000 shares of Phio Pharmaceuticals worth $51K as of Q2 2026.
Phio Pharmaceuticals was a new Nomura Asset Management International position in Q2 2026.
Phio Pharmaceuticals made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1329 holding.
24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.